Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
105.40    2.20 (2.13%)
Bid:
105.00
Ask:
105.80
Spread: 0.80 (0.762%)
Market Cap: £172.80m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

19 Oct 2009 07:00

RNS Number : 9424A
Yule Catto & Co PLC
19 October 2009
 



Yule Catto & Co plc 

Interim Management Statement

Yule Catto & Co plc, the international producer of speciality chemicals, today issues its interim management statement for the period 1 July to 30 September 2009.

The Group delivered a strong financial performance in the third quarter, exceeding the expectations of the Board at the time of its Interim Report.

In Polymer Chemicals, monomer prices increased as expected. Volumes, which were almost 15% down in the first half of the year, were less than 10% down in the quarter compared to quarter three 2008, bettering the anticipated 10-15% decline. This, together with continued good cost control and the weak pound, meant Polymers delivered a strong third quarter.

Pharma Chemicals is seasonally weak in the third quarter due to the summer shutdown period in continental Europe. We continued to see the lower volumes in the business that we experienced through the first half, but the business remains ahead of prior year as at the end of September. 

William Blythe's performance was in line with the first half of the current year, and is well ahead of last year for the nine month period.

The Group announced a number of cost reduction initiatives with its full year 2008 results which have delivered as planned.

Good progress was made on reducing Group net debt, which fell further during the quarter. In September the Group repaid the £33M current installment of its term loans, without recourse to its three year £30M revolving bank loan facility arranged in December 2008, which remained undrawn as at the end of September.

With the strong third quarter, Group profit before tax at the nine months is now well ahead of the same period last year. Raw material price rises are putting pressure on margins, and we are working to recover this through selling prices and this looks likely to persist throughout 2010. Substantial uncertainty about the global economic situation clearly remains. There has been some customer restocking during the first nine months, and whilst Polymer volumes will be ahead for the fourth quarter, we remain cautious about volume development in 2010. For the current year though, following the strong third quarter performance of the Group, the Board now expects full year underlying profit before tax for the group to substantially exceed 2008.

19 October 2009

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive 

David Blackwood, Group Finance Director 

 

Hogarth Partnership Limited

Tel: 020 7357 9477

Andrew Jaques

John Olsen

Ian Payne

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSILFESIALRLIA
Date   Source Headline
30th Jul 201912:54 pmRNSDirector/PDMR Shareholding
30th Jul 201912:53 pmRNSDirector/PDMR Shareholding
30th Jul 201912:52 pmRNSDirector/PDMR Shareholding
30th Jul 201912:51 pmRNSDirector/PDMR Shareholding
30th Jul 201912:50 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201912:48 pmRNSDirector/PDMR Shareholding
30th Jul 201911:31 amRNSResults of Rump Placing
30th Jul 20197:00 amRNSResults of Rights Issue
26th Jul 20192:48 pmRNSDirector/PDMR Shareholding
26th Jul 20192:46 pmRNSDirector/PDMR Shareholding
24th Jul 20194:34 pmRNSDirector Declaration
15th Jul 20197:00 amRNSAdmission of Nil Paid Rights
10th Jul 20191:49 pmRNSPublication of Circular and Prospectus
10th Jul 20191:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAcquisition
2nd Jul 20193:56 pmRNSDirector Declaration
13th Jun 201911:18 amRNSDirector Declaration
25th Apr 20194:45 pmRNSResult of AGM
25th Apr 20197:00 amRNSQ1 Trading Update
10th Apr 20194:51 pmRNSDirector/PDMR Shareholding
10th Apr 20194:50 pmRNSDirector/PDMR Shareholding
10th Apr 20194:43 pmRNSDirector/PDMR Shareholding
10th Apr 20194:41 pmRNSDirector/PDMR Shareholding
28th Mar 20193:51 pmRNSDirector/PDMR Shareholding
28th Mar 20193:50 pmRNSDirector/PDMR Shareholding
25th Mar 20193:15 pmRNSAnnual Financial Report
21st Mar 20193:39 pmRNSDirector Declaration
18th Mar 201910:02 amRNSDirector/PDMR Shareholding
12th Mar 201911:25 amRNSDirector/PDMR Shareholding
12th Mar 201911:23 amRNSDirector/PDMR Shareholding
5th Mar 20194:09 pmRNSDirector/PDMR Shareholding
4th Mar 20197:00 amRNSResults for the year ended 31 December 2018
1st Mar 20193:26 pmRNSDirector Declaration
3rd Dec 201810:54 amRNSHolding(s) in Company
9th Nov 201811:36 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSQ3 Trading update
17th Oct 20189:29 amRNSDirector Declaration
21st Sep 20189:17 amRNSDirectorate Change
6th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20186:25 pmRNSDirector/PDMR Shareholding
10th Jul 20189:47 amRNSHolding(s) in Company
4th Jul 201811:45 amRNSHolding(s) in Company
4th Jul 201811:44 amRNSHolding(s) in Company
4th Jul 201811:43 amRNSHolding(s) in Company
28th Jun 20183:12 pmRNSUpdate on Proposed Offering
25th Jun 20187:19 amRNSPROPOSED OFFERING OF EUR300M BOND & REFINANCING
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.